NATCO PHARMA LIMITED (INDIA)
"Bandrone" contains Drug / Molecule called “Ibandronic acid”. It belongs to a class of medications known as bisphosphonate. The action of ibandronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. It functions by preventing the breakdown of bone by bone cells known as osteoclasts. This activity inhibits osteoclast activity and reduces bone resorption and turnover.
Bandrone is used for the treatment and prevention of osteoporosis in postmenopausal women.
- Bandrone is a prescription drug and should be used under proper medical guidance and advice.
- Caution should be exercised in patients with history of allergy, taking any oral medications, undergoing radiation therapy, anemia, gastrointestinal problems including esophageal ulcer, cancer, infectious diseases, blood clotting problem, liver or kidney dis
- Contraindicated during pregnancy and lactation
50 mg (Tablets), 150 mg (Tablets), 06 mg (Vial)
50 mg - 1 X 10 Tablets (Strip) 150 mg - 1 X 1 Tablet (Strip) 06 mg - Single Dose Vial
Store at room Temperature (25 °C)
Was this page helpful?
Bandrone also available as
"Bondranat" contains Drug / Molecule called “Ibandronic acid”. Bondranat belongs to a class of medications known as bisphosphonate. Bondranat belongs to the bisphosphonate group of compounds which act specifically on bone. Their selective action on bone tissue is based on the high affinity of bisphosphonates for bone mineral.
“Bandrone” is the generic version of “Bondronat” and both contains same drug “Ibandronic Acid”